{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/78708"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/78708","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Spectroscopic characterization of iron-oxygen intermediates in human aromatase (CYP19A1)","abstract":"CYP19A1 or aromatase, is a human steroidogenic P450 important for estrogen biosynthesis in humans. Over activation of aromatase results in malignancies of the breast tissue, especially in post menopausal women. In fact, aromatase inhibitors constitute the front line therapy for estrogen receptor positive (ER+) breast cancer in post-menopausal women which accounts for over 70% of all breast cancer cases in the United States. Starting with its androgenic substrates, testosterone and androstenedione, CYP19A1 forms estradiol and estrone utilizing one molecule of atmospheric oxygen and two reducing equivalents in the form of NADPH. This is accomplished in a three-step process one of which involves a carbon-carbon bond scission and aromatization. The catalytic mechanism of P450s has been long studied and it is well known that an oxo-ferryl π-cation radical, known as “Compound 1” in P450 chemistry is the reactive intermediate that catalyzes most of the reactions of P450s. The identity of the reaction intermediate that catalyzes the terminal step estrogen biosynthesis by CYP19A1 is still a mystery. There is evidence in the literature suggesting the involvement of Compound 1 via a hydrogen abstraction that initiates deformylation and subsequent aromatization. There is also suggestion of the peroxo-anion or “Compound 0” acting as a nucleophile, attacking the electrophilic carbonyl carbon of 19-oxo-androstenedione forming a peroxide adduct that then fragments to produce acyl-carbon cleavage. Owing to the interesting chemistry CYP19A1 catalyzes and its role in human health I focused my attention towards elucidating the mechanism of this critical enzyme with the hope that a detailed picture of the workings of CYP19A1 will help guide efforts to make more specific inhibitors and improve breast cancer prognosis. CYP19A1 is a membrane-bound hemeprotein with a rich spectroscopic landscape thus affording an opportunity to apply a repertoire of biophysical approaches to help piece together a reaction mechanism. I used the Nanodisc technology to stabilize CYP19A1 in its native membrane-like environment to obtain a mono-disperse, stable and homogenous enzyme preparation that is amicable to the optical, resonance Raman (rR) and electron paramagnetic resonance (EPR) spectroscopy and also, cryoradiolysis and cryospectroscopy. The approach I have applied in this project has been that of characterizing the individual fate of reaction intermediates on their way from substrates to products thereby catching them ‘in action’. My cryospectroscopy, EPR, rR and steady state kinetics efforts outlined in this doctoral thesis all implicate “Compound 1” as the reactive intermediate that is responsible for the carbon-carbon scission reactivity of CYP19A1.","abstract_html":"CYP19A1 or aromatase, is a human steroidogenic P450 important for estrogen biosynthesis in humans. Over activation of aromatase results in malignancies of the breast tissue, especially in post menopausal women. In fact, aromatase inhibitors constitute the front line therapy for estrogen receptor positive (ER+) breast cancer in post-menopausal women which accounts for over 70% of all breast cancer cases in the United States. Starting with its androgenic substrates, testosterone and androstenedione, CYP19A1 forms estradiol and estrone utilizing one molecule of atmospheric oxygen and two reducing equivalents in the form of NADPH. This is accomplished in a three-step process one of which involves a carbon-carbon bond scission and aromatization. The catalytic mechanism of P450s has been long studied and it is well known that an oxo-ferryl π-cation radical, known as “Compound 1” in P450 chemistry is the reactive intermediate that catalyzes most of the reactions of P450s. The identity of the reaction intermediate that catalyzes the terminal step estrogen biosynthesis by CYP19A1 is still a mystery. There is evidence in the literature suggesting the involvement of Compound 1 via a hydrogen abstraction that initiates deformylation and subsequent aromatization. There is also suggestion of the peroxo-anion or “Compound 0” acting as a nucleophile, attacking the electrophilic carbonyl carbon of 19-oxo-androstenedione forming a peroxide adduct that then fragments to produce acyl-carbon cleavage. Owing to the interesting chemistry CYP19A1 catalyzes and its role in human health I focused my attention towards elucidating the mechanism of this critical enzyme with the hope that a detailed picture of the workings of CYP19A1 will help guide efforts to make more specific inhibitors and improve breast cancer prognosis. CYP19A1 is a membrane-bound hemeprotein with a rich spectroscopic landscape thus affording an opportunity to apply a repertoire of biophysical approaches to help piece together a reaction mechanism. I used the Nanodisc technology to stabilize CYP19A1 in its native membrane-like environment to obtain a mono-disperse, stable and homogenous enzyme preparation that is amicable to the optical, resonance Raman (rR) and electron paramagnetic resonance (EPR) spectroscopy and also, cryoradiolysis and cryospectroscopy. The approach I have applied in this project has been that of characterizing the individual fate of reaction intermediates on their way from substrates to products thereby catching them ‘in action’. My cryospectroscopy, EPR, rR and steady state kinetics efforts outlined in this doctoral thesis all implicate “Compound 1” as the reactive intermediate that is responsible for the carbon-carbon scission reactivity of CYP19A1.","abstract_has_math":false,"creators":["Luthra, Abhinav"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Biochemistry","degree_department":null,"school":null,"contributors":["Sligar, Stephen G.","Martinis, Susan A.","Hergenrother, Paul J.","Kranz, David M."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-07-22T22:44:57Z","date_published":"2015-07-22T22:44:57Z","updated_at":"2026-07-22T22:26:12Z","subjects":["Conformational Substates of P450s","Temperature Derivative Spectroscopy","Compound 1","Peroxo-anion","Aromatization","C-C Scission","P450","Human Aromatase","CYP19A1"],"languages":[],"rights":["Copyright 2015 Abhinav Luthra"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/78708","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Sligar, Stephen G.","Martinis, Susan A.","Hergenrother, Paul J.","Kranz, David M."]},{"key":"dc:creator","label":"Author","values":["Luthra, Abhinav"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015-07-22T22:44:57Z","2017-07-23T09:15:17Z","2015-05","2015-02-25","2015-5"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Conformational Substates of P450s","Temperature Derivative Spectroscopy","Compound 1","Peroxo-anion","Aromatization","C-C Scission","P450","Human Aromatase","CYP19A1"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2015 Abhinav Luthra"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/78708"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["CYP19A1 or aromatase, is a human steroidogenic P450 important for estrogen biosynthesis in humans. Over activation of aromatase results in malignancies of the breast tissue, especially in post menopausal women. In fact, aromatase inhibitors constitute the front line therapy for estrogen receptor positive (ER+) breast cancer in post-menopausal women which accounts for over 70% of all breast cancer cases in the United States. Starting with its androgenic substrates, testosterone and androstenedione, CYP19A1 forms estradiol and estrone utilizing one molecule of atmospheric oxygen and two reducing equivalents in the form of NADPH. This is accomplished in a three-step process one of which involves a carbon-carbon bond scission and aromatization. The catalytic mechanism of P450s has been long studied and it is well known that an oxo-ferryl π-cation radical, known as “Compound 1” in P450 chemistry is the reactive intermediate that catalyzes most of the reactions of P450s. The identity of the reaction intermediate that catalyzes the terminal step estrogen biosynthesis by CYP19A1 is still a mystery. There is evidence in the literature suggesting the involvement of Compound 1 via a hydrogen abstraction that initiates deformylation and subsequent aromatization. There is also suggestion of the peroxo-anion or “Compound 0” acting as a nucleophile, attacking the electrophilic carbonyl carbon of 19-oxo-androstenedione forming a peroxide adduct that then fragments to produce acyl-carbon cleavage. Owing to the interesting chemistry CYP19A1 catalyzes and its role in human health I focused my attention towards elucidating the mechanism of this critical enzyme with the hope that a detailed picture of the workings of CYP19A1 will help guide efforts to make more specific inhibitors and improve breast cancer prognosis. CYP19A1 is a membrane-bound hemeprotein with a rich spectroscopic landscape thus affording an opportunity to apply a repertoire of biophysical approaches to help piece together a reaction mechanism. I used the Nanodisc technology to stabilize CYP19A1 in its native membrane-like environment to obtain a mono-disperse, stable and homogenous enzyme preparation that is amicable to the optical, resonance Raman (rR) and electron paramagnetic resonance (EPR) spectroscopy and also, cryoradiolysis and cryospectroscopy. The approach I have applied in this project has been that of characterizing the individual fate of reaction intermediates on their way from substrates to products thereby catching them ‘in action’. My cryospectroscopy, EPR, rR and steady state kinetics efforts outlined in this doctoral thesis all implicate “Compound 1” as the reactive intermediate that is responsible for the carbon-carbon scission reactivity of CYP19A1.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2017-05-01","The student, Abhinav Luthra, accepted the attached license on 2015-01-20 at 17:17.","The student, Abhinav Luthra, submitted this Dissertation for approval on 2015-01-21 at 11:40.","This Dissertation was approved for publication on 2015-02-25 at 15:46.","DSpace SAF Submission Ingestion Package generated from Vireo submission #7691 on 2015-07-22 at 14:23:53","Made available in DSpace on 2015-07-22T22:44:57Z (GMT). No. of bitstreams: 2 Luthra_Abhinav.pdf: 13338061 bytes, checksum: 5e39e44030991e9ba83c7f2a97dff272 (MD5) license.txt: 4063 bytes, checksum: 4fe24235dd8d08f43e3ef345b01b0f88 (MD5) Previous issue date: 2015-02-25","Embargo set by: Seth Robbins for item 79949 Lift date: 2017-07-22T22:46:21Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 79949 on 2017-07-23T09:15:17Z."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Spectroscopic characterization of iron-oxygen intermediates in human aromatase (CYP19A1)"]}]}],"canonical_facts":{"dc:contributor":["Sligar, Stephen G.","Martinis, Susan A.","Hergenrother, Paul J.","Kranz, David M."],"dc:creator":["Luthra, Abhinav"],"dc:date":["2015-07-22T22:44:57Z","2017-07-23T09:15:17Z","2015-05","2015-02-25","2015-5"],"dc:description":["CYP19A1 or aromatase, is a human steroidogenic P450 important for estrogen biosynthesis in humans. Over activation of aromatase results in malignancies of the breast tissue, especially in post menopausal women. In fact, aromatase inhibitors constitute the front line therapy for estrogen receptor positive (ER+) breast cancer in post-menopausal women which accounts for over 70% of all breast cancer cases in the United States. Starting with its androgenic substrates, testosterone and androstenedione, CYP19A1 forms estradiol and estrone utilizing one molecule of atmospheric oxygen and two reducing equivalents in the form of NADPH. This is accomplished in a three-step process one of which involves a carbon-carbon bond scission and aromatization. The catalytic mechanism of P450s has been long studied and it is well known that an oxo-ferryl π-cation radical, known as “Compound 1” in P450 chemistry is the reactive intermediate that catalyzes most of the reactions of P450s. The identity of the reaction intermediate that catalyzes the terminal step estrogen biosynthesis by CYP19A1 is still a mystery. There is evidence in the literature suggesting the involvement of Compound 1 via a hydrogen abstraction that initiates deformylation and subsequent aromatization. There is also suggestion of the peroxo-anion or “Compound 0” acting as a nucleophile, attacking the electrophilic carbonyl carbon of 19-oxo-androstenedione forming a peroxide adduct that then fragments to produce acyl-carbon cleavage. Owing to the interesting chemistry CYP19A1 catalyzes and its role in human health I focused my attention towards elucidating the mechanism of this critical enzyme with the hope that a detailed picture of the workings of CYP19A1 will help guide efforts to make more specific inhibitors and improve breast cancer prognosis. CYP19A1 is a membrane-bound hemeprotein with a rich spectroscopic landscape thus affording an opportunity to apply a repertoire of biophysical approaches to help piece together a reaction mechanism. I used the Nanodisc technology to stabilize CYP19A1 in its native membrane-like environment to obtain a mono-disperse, stable and homogenous enzyme preparation that is amicable to the optical, resonance Raman (rR) and electron paramagnetic resonance (EPR) spectroscopy and also, cryoradiolysis and cryospectroscopy. The approach I have applied in this project has been that of characterizing the individual fate of reaction intermediates on their way from substrates to products thereby catching them ‘in action’. My cryospectroscopy, EPR, rR and steady state kinetics efforts outlined in this doctoral thesis all implicate “Compound 1” as the reactive intermediate that is responsible for the carbon-carbon scission reactivity of CYP19A1.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2017-05-01","The student, Abhinav Luthra, accepted the attached license on 2015-01-20 at 17:17.","The student, Abhinav Luthra, submitted this Dissertation for approval on 2015-01-21 at 11:40.","This Dissertation was approved for publication on 2015-02-25 at 15:46.","DSpace SAF Submission Ingestion Package generated from Vireo submission #7691 on 2015-07-22 at 14:23:53","Made available in DSpace on 2015-07-22T22:44:57Z (GMT). No. of bitstreams: 2 Luthra_Abhinav.pdf: 13338061 bytes, checksum: 5e39e44030991e9ba83c7f2a97dff272 (MD5) license.txt: 4063 bytes, checksum: 4fe24235dd8d08f43e3ef345b01b0f88 (MD5) Previous issue date: 2015-02-25","Embargo set by: Seth Robbins for item 79949 Lift date: 2017-07-22T22:46:21Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 79949 on 2017-07-23T09:15:17Z."],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/78708"],"dc:rights":["Copyright 2015 Abhinav Luthra"],"dc:subject":["Conformational Substates of P450s","Temperature Derivative Spectroscopy","Compound 1","Peroxo-anion","Aromatization","C-C Scission","P450","Human Aromatase","CYP19A1"],"dc:title":["Spectroscopic characterization of iron-oxygen intermediates in human aromatase (CYP19A1)"],"dc:type":["text"],"thesis:degree_discipline":["Biochemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:12Z"}